The conventional diagnostic method typically classifies HER2 IHC into negative (0 and 1+), equivocal (2+), and positive (3+), based on the intensity of HER2 membranous staining and the percentage of tumor cells that show this staining [64]. Here, ERBB2 is linked to neoplasm.